stockrow
Friday 6 November 2026
Export MMED’s income statement to Excel — free account
MiniMed Group, Inc.
MMED Healthcare Medical Instruments & Supplies
MiniMed Group, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $3.1 billion, up 14.3% from fiscal 2025.
18.23
1.06
−5.50%
Follow MMED
Alert me
| Older periods | Jul '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
|
+2 more TTM periods Free account |
— | — | — | 0.00% | |
| — | 0.00% | 0.00% | (6.27%) | ||
ROIC |
0.00% | 0.00% | 0.00% | (1.61%) | |
Return on Tangible Assets |
— | 0.00% | 0.00% | (10.80%) | |
Average Days of Receivables |
— | 0.00 | 0.00 | 21.59 | |
Free Cash Flow per Share |
(1.40) | (1.74) | — | (1.61) | |
Free Cash Flow |
(354.00) | (441.00) | — | (452.00) | |
Capital Expenditures |
(394.00) | (413.00) | — | (318.00) | |
| Other line items | |||||
Cash ROIC |
0.00% | (12.70%) | 0.00% | (11.81%) | |
Accounts Receivable Turnover |
— | — | — | 0.00 | |
Accounts Payable Turnover |
— | — | — | 0.00 | |
Inventory Turnover |
— | — | — | 0.00 | |
Average Days of Payables |
— | 0.00 | 0.00 | 64.88 | |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 92.03 | |
Tax Rate |
— | — | — | 0.54 | |
Research and Development Expense of Revenue |
— | — | — | 15.31% | |
Selling, General and Administrative Expense of Revenue |
— | — | — | 38.51% | |
Share Based Compensation of Revenue |
— | — | — | 2.92% | |
Operating CF/Net income |
0.00 | 0.00 | — | 0.91 | |
Depreciation/Fixed assets |
0.00 | 0.43 | 0.00 | 0.32 | |
Capex/Depreciation |
(1.27) | (1.38) | — | (1.35) | |
Revenue per Share |
0.00 | 0.00 | — | 10.83 | |
Operating CF per Share |
0.16 | (0.11) | — | (0.48) | |
Capex per Share |
(1.56) | (1.63) | — | (1.13) | |
Capex to Sales |
0.00 | 0.00 | — | 0.10 |
Columns are period end dates · fundamentals updated 26 Oct 2026